Surgery Partners Long Term Debt 2013-2024 | SGRY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Surgery Partners long term debt from 2013 to 2024. Long term debt can be defined as the sum of all long term debt fields.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Surgery Partners long term debt from 2013 to 2024. Long term debt can be defined as the sum of all long term debt fields.

Related Stocks
Company Name	Market Cap
Elevance Health (ELV)	$88.4B
Cencora (COR)	$45.7B
Natera (NTRA)	$23.1B
DiDi Global (DIDIY)	$22B
ICON (ICLR)	$18B
Avantor (AVTR)	$14.7B
Viatris (VTRS)	$13.9B
Revvity (RVTY)	$13.9B
BioMerieux (BMXMF)	$12.6B
CochLear (CHEOY)	$12.1B
Solventum (SOLV)	$11.6B
Medpace Holdings (MEDP)	$10.9B
Doximity (DOCS)	$9.7B
EUROFINS SCIENT (ERFSF)	$9.7B
Charles River Laboratories (CRL)	$9.5B
HealthEquity (HQY)	$8.7B
Sonic Healthcare (SKHHY)	$8.2B
Bausch + Lomb (BLCO)	$6.3B
Amplifon S.p.A (AMFPF)	$5.9B
Organon (OGN)	$4.1B
Sotera Health (SHC)	$3.7B
BrightSpring Health Services (BTSG)	$3B
Concentras Parent (CON)	$2.5B
GeneDx Holdings (WGS)	$2.5B
Alignment Healthcare (ALHC)	$2.3B
Ardent Health Partners (ARDT)	$2.3B
Premier (PINC)	$2B
PACS (PACS)	$2B
GoodRx Holdings (GDRX)	$1.7B
Teladoc Health (TDOC)	$1.7B